http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#Head
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#assertion
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#provenance
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#pubinfo
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#assertion
http://purl.obolibrary.org/obo/DOID_5408
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_5408
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB01077
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#association
http://www.w3.org/2000/01/rdf-schema#label
etidronate disodium tablets usp are indicated for the treatment of symptomatic paget s disease of bone and in the prevention and treatment of heterotopic ossification following total hip replacement or due to spinal cord injury etidronate disodium tablets are not approved for the treatment of osteoporosis etidronate disodium tablets are indicated for the treatment of symptomatic paget s disease of bone etidronate disodium therapy usually arrests or significantly impedes the disease process as evidenced by in addition reductions in pagetically elevated cardiac output and skin temperature have been observed in some patients in many patients the disease process will be suppressed for a period of at least one year following cessation of therapy the upper limit of this period has not been determined the effects of the etidronate disodium treatment in patients with asymptomatic paget s disease have not been studied however etidronate disodium treatment of such patients may be warranted if extensive involvement threatens irreversible neurologic damage major joints or major weight bearing bones etidronate disodium tablets are indicated in the prevention and treatment of heterotopic ossification following total hip replacement or due to spinal cord injury etidronate disodium tablets reduce the incidence of clinically important heterotopic bone by about two thirds among those patients who form heterotopic bone etidronate disodium tablets retard the progression of immature lesions and reduces the severity by at least half follow up data at least 9 months post therapy suggests these benefits persist in total hip replacement patients in spinal cord injury patients
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#association
https://w3id.org/biolink/vocab/relation
https://w3id.org/um/neurodkg/SymptomaticReliefIndication
https://identifiers.org/drugbank:DB01077
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#provenance
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#pubinfo
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#sig
http://purl.org/nanopub/x/hasSignature
FYyLE+nuyGcwqac8BWpkcQy1iENzql6mcS8/efGHsJNwmonirIibroRSYj5ecpNLcAtEiMyvd62qobW8L48H1O4brtHB10QiaDFLWzwWf1wFL/wwgT6i4Zy0CYOkJqEiFcoNP12WqSu5E3TXGdVNC/HXQMHY49+BH69DSBiQ1Xg=
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI
http://purl.org/dc/terms/created
2021-06-13T12:30:04.305+02:00
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAAKC0Z4kycyc8-KR5wCHbvBSgEdSt0KKn9RnK9coWCTI
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs